Clinical Trial Update: Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis [Phase 1]

View source ↗

Summary

A Phase 1 safety/efficacy trial for amyotrophic lateral sclerosis sponsored by TCA Cellular Therapy has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• TCA Cellular Therapy

Snippet

Sponsor: TCA Cellular Therapy | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: SUSPENDED